Ligand ID: LF7


Drugbank ID:
DB04876
(Vildagliptin)


Indication:
Used to reduce hyperglycemia in type 2 diabetes mellitus.

Get human targets for LF7 in PDB (known and potential targets)

RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES MAPPED TO LIGAND 'LF7'

Click here for results that match SARS-Cov-2 / COVID-19 structures only
Click here for results that match SARS-related structures only


1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 View Interface RMSD Seq.
Identity (%)		 HETATM Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B1E_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		1uk4 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 11
ARG B 298
TYR A 118
VAL A 114
TYR A 126
VAL A 125
1.77A16.29
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W2T_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		1uk4 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
ARG B 298
TYR A 118
VAL A 114
TYR A 126
VAL A 125
1.75A16.19
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B1E_B_LF7B801_1
(DIPEPTIDYL PEPTIDASE
4)		1x7q HLA, A-11
(Homo
sapiens)		5 / 12
ARG A 163
TYR A  59
TYR A   7
ASN A  66
VAL A  67
1.78A18.10
SO4  A4003 (-4.0A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W2T_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		1x7q HLA, A-11
(Homo
sapiens)		5 / 12
ARG A 163
TYR A  59
TYR A   7
ASN A  66
VAL A  67
1.78A18.09
SO4  A4003 (-4.0A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B1E_B_LF7B801_1
(DIPEPTIDYL PEPTIDASE
4)		1z1j 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
ARG A 298
TYR B1118
VAL B1114
TYR B1126
VAL B1125
1.78A16.29
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B1E_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		1z1j 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 11
ARG A 298
TYR B1118
VAL B1114
TYR B1126
VAL B1125
1.79A16.29
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W2T_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		1z1j 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
ARG A 298
TYR B1118
VAL B1114
TYR B1126
VAL B1125
1.79A16.19
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B1E_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		2amq 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 11
ARG B 298
TYR A 118
VAL A 114
TYR A 126
VAL A 125
1.78A16.19
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B1E_B_LF7B801_1
(DIPEPTIDYL PEPTIDASE
4)		2amq 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
ARG B 298
TYR A 118
VAL A 114
TYR A 126
VAL A 125
1.76A16.19
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B1E_B_LF7B801_1
(DIPEPTIDYL PEPTIDASE
4)		2duc REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		5 / 12
ARG B 298
TYR A 118
VAL A 114
TYR A 126
VAL A 125
1.75A16.29
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B1E_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		2fe8 REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		5 / 11
ARG C 285
GLU C 264
SER C 116
VAL C 166
TYR C 265
1.66A17.61
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W2T_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		2fe8 REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		5 / 12
ARG C 285
GLU C 264
SER C 116
VAL C 166
TYR C 265
1.65A17.33
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B1E_B_LF7B801_1
(DIPEPTIDYL PEPTIDASE
4)		2fe8 REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		5 / 12
ARG C 285
GLU C 264
SER C 116
VAL C 166
TYR C 265
1.66A17.61
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W2T_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		3aw1 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
ARG B 298
TYR A 118
VAL A 114
TYR A 126
VAL A 125
1.76A16.19
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B1E_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		3aw1 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 11
ARG B 298
TYR A 118
VAL A 114
TYR A 126
VAL A 125
1.77A16.29
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B1E_B_LF7B801_1
(DIPEPTIDYL PEPTIDASE
4)		3aw1 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
ARG B 298
TYR A 118
VAL A 114
TYR A 126
VAL A 125
1.76A16.29
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W2T_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		3e9s NSP3
(SARSr-CoV)		5 / 12
ARG A 285
GLU A 264
SER A 116
VAL A 166
TYR A 265
1.79A17.45
None
None
OCS  A 112 ( 3.7A)
None
TTT  A 317 (-4.1A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B1E_B_LF7B801_1
(DIPEPTIDYL PEPTIDASE
4)		3to2 MHC CLASS I ANTIGEN
(Homo
sapiens)		5 / 12
TYR A  85
TYR A  84
TYR A 116
TYR A 123
VAL A  95
1.74A18.15
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W2T_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		3to2 MHC CLASS I ANTIGEN
(Homo
sapiens)		5 / 12
TYR A  85
TYR A  84
TYR A 116
TYR A 123
VAL A  95
1.74A18.14
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B1E_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		3to2 MHC CLASS I ANTIGEN
(Homo
sapiens)		5 / 11
TYR A  85
TYR A  84
TYR A 116
TYR A 123
VAL A  95
1.75A18.15
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B1E_B_LF7B801_1
(DIPEPTIDYL PEPTIDASE
4)		5e6j REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		5 / 12
GLU D 239
TYR D 214
TYR D 311
VAL D 236
VAL D 185
1.69A17.61
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B1E_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		5e6j REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		5 / 11
GLU D 239
TYR D 214
TYR D 311
VAL D 236
VAL D 185
1.68A17.61
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W2T_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		5e6j REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		5 / 12
GLU D 239
TYR D 214
TYR D 311
VAL D 236
VAL D 185
1.68A18.11
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B1E_B_LF7B801_1
(DIPEPTIDYL PEPTIDASE
4)		5tl6 REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		5 / 12
ARG D 139
GLU D 135
TYR D  84
VAL D  12
TYR D  72
1.66A17.31
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W2T_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		5x5c S PROTEIN
(MERS-CoV)		5 / 12
GLU B 513
TYR C 409
VAL C 575
TYR C 577
ASN C 582
1.64A21.61
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B1E_B_LF7B801_1
(DIPEPTIDYL PEPTIDASE
4)		6crw SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 12
ARG B 183
GLU B  93
VAL B 140
ASN B  96
VAL B 172
1.75A21.18
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B1E_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		6crw SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 11
ARG B 183
GLU B  93
VAL B 140
ASN B  96
VAL B 172
1.74A21.18
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W2T_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		6crw SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 12
ARG B 183
GLU B  93
VAL B 140
ASN B  96
VAL B 172
1.75A21.20
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W2T_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 12
ARG D 298
TYR B 118
VAL B 114
TYR B 126
VAL B 125
1.79A15.91
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W2T_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		6y2g REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
ARG A 298
TYR B 118
VAL B 114
TYR B 126
VAL B 125
1.80A15.91
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W2T_B_LF7B801_1
(DIPEPTIDYL PEPTIDASE
4)		6yla LIGHT CHAIN
(Homo
sapiens)		5 / 12
TYR L 102
SER L  99
TYR L  97
VAL L  29
TYR L  31
1.76A15.89
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B1E_B_LF7B801_1
(DIPEPTIDYL PEPTIDASE
4)		6yla LIGHT CHAIN
(Homo
sapiens)		5 / 12
TYR L 102
SER L  99
TYR L  97
VAL L  29
TYR L  31
1.78A18.41
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B1E_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		6yla LIGHT CHAIN
(Homo
sapiens)		5 / 11
TYR L 102
SER L  99
TYR L  97
VAL L  29
TYR L  31
1.77A18.41
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B1E_B_LF7B801_1
(DIPEPTIDYL PEPTIDASE
4)		6yla LIGHT CHAIN
(Homo
sapiens)		5 / 12
TYR C 102
SER C  99
TYR C  97
VAL C  29
TYR C  31
1.78A18.41
None
DMS  C 303 (-4.1A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B1E_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		6yla LIGHT CHAIN
(Homo
sapiens)		5 / 11
TYR C 102
SER C  99
TYR C  97
VAL C  29
TYR C  31
1.77A18.41
None
DMS  C 303 (-4.1A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W2T_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		6yla LIGHT CHAIN
(Homo
sapiens)		5 / 12
TYR L 102
SER L  99
TYR L  97
VAL L  29
TYR L  31
1.75A15.89
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W2T_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		6yla LIGHT CHAIN
(Homo
sapiens)		5 / 12
TYR C 102
SER C  99
TYR C  97
VAL C  29
TYR C  31
1.75A15.89
None
DMS  C 303 (-4.1A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W2T_B_LF7B801_1
(DIPEPTIDYL PEPTIDASE
4)		6yla LIGHT CHAIN
(Homo
sapiens)		5 / 12
TYR C 102
SER C  99
TYR C  97
VAL C  29
TYR C  31
1.75A15.89
None
DMS  C 303 (-4.1A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B1E_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		6ym0 LIGHT CHAIN
(Homo
sapiens)		5 / 11
TYR L 102
SER L  99
TYR L  97
VAL L  29
TYR L  31
1.74A18.41
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W2T_B_LF7B801_1
(DIPEPTIDYL PEPTIDASE
4)		6ym0 LIGHT CHAIN
(Homo
sapiens)		5 / 12
TYR L 102
SER L  99
TYR L  97
VAL L  29
TYR L  31
1.73A15.89
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B1E_B_LF7B801_1
(DIPEPTIDYL PEPTIDASE
4)		6ym0 LIGHT CHAIN
(Homo
sapiens)		5 / 12
TYR L 102
SER L  99
TYR L  97
VAL L  29
TYR L  31
1.75A18.41
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W2T_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		6ym0 LIGHT CHAIN
(Homo
sapiens)		5 / 12
TYR L 102
SER L  99
TYR L  97
VAL L  29
TYR L  31
1.72A15.89
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B1E_B_LF7B801_1
(DIPEPTIDYL PEPTIDASE
4)		6yor IGG L CHAIN
(Homo
sapiens)		5 / 12
TYR L 102
SER L  99
TYR L  97
VAL L  29
TYR L  31
1.77A18.41
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W2T_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		6yor IGG L CHAIN
(Homo
sapiens)		5 / 12
TYR C 102
SER C  99
TYR C  97
VAL C  29
TYR C  31
1.75A15.89
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W2T_B_LF7B801_1
(DIPEPTIDYL PEPTIDASE
4)		6yor IGG L CHAIN
(Homo
sapiens)		5 / 12
TYR L 102
SER L  99
TYR L  97
VAL L  29
TYR L  31
1.75A15.89
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W2T_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		6yor IGG L CHAIN
(Homo
sapiens)		5 / 12
TYR L 102
SER L  99
TYR L  97
VAL L  29
TYR L  31
1.74A15.89
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B1E_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		6yor IGG L CHAIN
(Homo
sapiens)		5 / 11
TYR L 102
SER L  99
TYR L  97
VAL L  29
TYR L  31
1.77A18.41
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W2T_B_LF7B801_1
(DIPEPTIDYL PEPTIDASE
4)		6yor IGG L CHAIN
(Homo
sapiens)		5 / 12
TYR C 102
SER C  99
TYR C  97
VAL C  29
TYR C  31
1.76A15.89
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B1E_B_LF7B801_1
(DIPEPTIDYL PEPTIDASE
4)		6yor IGG L CHAIN
(Homo
sapiens)		5 / 12
TYR C 102
SER C  99
TYR C  97
VAL C  29
TYR C  31
1.78A18.41
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B1E_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		6yor IGG L CHAIN
(Homo
sapiens)		5 / 11
TYR C 102
SER C  99
TYR C  97
VAL C  29
TYR C  31
1.77A18.41
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B1E_B_LF7B801_1
(DIPEPTIDYL PEPTIDASE
4)		7bv2 NSP12
(SARS-CoV-2)		5 / 12
ARG A 654
GLU A 658
SER A 564
VAL A 560
ASN A 568
1.34A20.04
None
None
None
U  T  10 ( 4.6A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B1E_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		7bv2 NSP12
(SARS-CoV-2)		5 / 11
ARG A 654
GLU A 658
SER A 564
VAL A 560
ASN A 568
1.33A20.04
None
None
None
U  T  10 ( 4.6A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W2T_A_LF7A801_1
(DIPEPTIDYL PEPTIDASE
4)		7bv2 NSP12
(SARS-CoV-2)		5 / 12
ARG A 654
GLU A 658
SER A 564
VAL A 560
ASN A 568
1.36A20.56
None
None
None
U  T  10 ( 4.6A)
None